Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven V Edelman

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Journal of Diabetes Science and Technology|August 18, 2016
Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 DiabetesJeremy Pettus, Steven V Edelman
Diabetes Technology & Therapeutics|January 20, 2016
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose MonitoringJeremy Pettus, Steven V Edelman
Journal of Diabetes Science and Technology|April 6, 2016
Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM)Jeremy Pettus, Steven V Edelman
The Medical Clinics of North America|August 17, 2004
Insulin therapy in type 2 diabetesTrent Davis, Steven V Edelman
Clinical Diabetes : a Publication of the American Diabetes Association|February 8, 2021
Practical Strategies to Help Reduce Added Sugars Consumption to Support Glycemic and Weight Management GoalsHope Warshaw, Steven V Edelman
Diabetes, Obesity & Metabolism|May 14, 2019
Sodium-glucose co-transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trialsSchafer Boeder, Steven V Edelman
The Diabetes Educator|June 6, 2006
Amylin replacement therapy in patients with type 1 diabetesSteven V Edelman, Leo Caballero
Diabetes Technology & Therapeutics|June 25, 2002
Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormoneSteven V Edelman, C Weyer
Southern Medical Journal|November 7, 2007
The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemiaCharles Choe, Steven V Edelman
Current Diabetes Reports|February 7, 2004
BNP levels to screen for left ventricular dysfunctionNeelima V Chu, Steven V Edelman
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Journal of Diabetes Science and Technology|August 18, 2016
Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 DiabetesJeremy Pettus, Steven V Edelman
Diabetes Technology & Therapeutics|January 20, 2016
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose MonitoringJeremy Pettus, Steven V Edelman
Journal of Diabetes Science and Technology|April 6, 2016
Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM)Jeremy Pettus, Steven V Edelman
The Medical Clinics of North America|August 17, 2004
Insulin therapy in type 2 diabetesTrent Davis, Steven V Edelman
Clinical Diabetes : a Publication of the American Diabetes Association|February 8, 2021
Practical Strategies to Help Reduce Added Sugars Consumption to Support Glycemic and Weight Management GoalsHope Warshaw, Steven V Edelman
Diabetes, Obesity & Metabolism|May 14, 2019
Sodium-glucose co-transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trialsSchafer Boeder, Steven V Edelman
The Diabetes Educator|June 6, 2006
Amylin replacement therapy in patients with type 1 diabetesSteven V Edelman, Leo Caballero
Diabetes Technology & Therapeutics|June 25, 2002
Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormoneSteven V Edelman, C Weyer
Southern Medical Journal|November 7, 2007
The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemiaCharles Choe, Steven V Edelman
Current Diabetes Reports|February 7, 2004
BNP levels to screen for left ventricular dysfunctionNeelima V Chu, Steven V Edelman
Pageof 9